CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus: Potential implication in eosinophil recruitment

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 586-592

  Tillie Leblond, I ^a   Hammad, H ^a   Desurmont, S ^a   Pugin, J ^a   Wallaert, B ^a   Tonnel, A B ^a   Gosset, P ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CYTOKINE; EOTAXIN; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1; RANTES;

ADULT; ARTICLE; ASTHMATIC STATE; CELL COUNT; CELL FUNCTION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; EOSINOPHIL; FIBEROPTIC BRONCHOSCOPY; HUMAN; LUNG LAVAGE; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0033845865     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.9907014     Document Type: Article

References (38)

1. Bronchial biopsies in asthma
2. Damage of the airway epithelium and bronchial reactivity in patients with asthma
3. Cellular events in the bronchi in mild asthma and after bronchial provocation
4. Causes of death and pathologic findings in 304 cases of bronchial asthma
5. Death in asthmatics
6. The structure of large and small airways in nonfatal and fatal asthma
7. Sudden-onset fatal asthma: Distinct entity with few neutrophils and relatively more neutrophils in the airway submucosa?
8. Bronchial neutrophilia in patients with noninfectious status asthmaticus
9. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo
10. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
11. Regulation and modulation of eosinophil effector functions
12. Chemokines and IL-5: Major players of eosinophil recruitment in asthma
13. Monocyte chemotatic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody
14. Monocyte chemotactic protein-3 is a most effective basophil- and eosinophil-activating chemokine
15. RANTES is a chemotactic and activating factor for human eosinophils
16. RANTES and macrophage inflammatory protein-1α induce the migration and activation of normal human eosinophil granulocytes
17. Monocyte chemotactic and activating factor/monocyte chemoattractant protein in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis: Relationship to lung function tests, bronchial hyper-responsiveness and cytology of bronchoalveolar lavage fluid
18. Recombinant human interleukin-5 is a selective eosinophil chemoattractant
19. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects
20. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor
21. Proinflammatory activity in bronchial lavage fluids of status asthmaticus patients
22. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
23. Heterogeneity of bronchial asthma: Subpopulations or different stages of the disease
24. Biopsy and possible efficacy of fiberoptic bronchoscopy with lavage in the management of refractory asthma with mucous impaction
25. Presence of factors chemotactic for granulocytes in hypereo-sinophilic syndrome sera: Relation with alterations in eosinophil migration
26. Cooperation between interleukin-5 and the chemokine, eotaxin, to induce eosinophil accumulation in vivo
27. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: Relationship to the eosinophil-active cytokines interleukin (IL)-5. Granulocyte macrophage-colony stimulating factor, and IL-3
28. Increased expression of eotaxin in bronchioalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
29. Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients
30. Release of RANTES, MIP-1α and MCP-1 into asthmatic airways following endobronchial allergen challenge
31. Eosinophil recruitment following endobronchial allergen challenge is associated with the release of RANTES into asthmatic airways
32. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
33. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
34. Expression of the chemokine RANTES by a human bronchial epithelial cell line: Modulation by cytokines and glucocorticoids
35. The cis-acting phorbol ester 12-O-tetradecanoylphorbol 13-acetate-responsive element is involved in shear stress-induced monocyte chemotactic protein-1 gene expression
36. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects
37. CC chemokines differentially alter interleukin-4 production from lymphocytes
38. Not another cytokine: MCP-1 and respiratory disease